Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ocular Genomics Institute, |
RCV001376387 | SCV001573507 | uncertain significance | Bardet-Biedl syndrome 1 | 2021-04-08 | criteria provided, single submitter | research | The BBS1 c.227T>A variant was identified in an individual with retinitis pigmentosa with a presumed recessive inheritance pattern. Through a review of available evidence we were able to apply the following criteria: PM2. Based on this evidence we have classified this variant as Variant of Uncertain Significance. |
Labcorp Genetics |
RCV001871987 | SCV002265687 | uncertain significance | Bardet-Biedl syndrome | 2022-04-07 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 1065728). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). This variant has not been reported in the literature in individuals affected with BBS1-related conditions. This sequence change replaces valine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 76 of the BBS1 protein (p.Val76Glu). This variant is not present in population databases (gnomAD no frequency). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |